| Kelly Thompson, | |
|
1400 Hulman St, Terre Haute, IN 47802-2536 | |
| (812) 232-6305 | |
| (812) 234-3683 |
| Full Name | Kelly Thompson |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1400 Hulman St, Terre Haute, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487337804 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 22006158A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelly Thompson, 1400 Hulman St, Terre Haute, IN 47802-2536 Ph: (812) 232-6305 | Kelly Thompson, 1400 Hulman St, Terre Haute, IN 47802-2536 Ph: (812) 232-6305 |
News Archive
Women with BRCA1 mutations may have an increased risk for developing rare types of aggressive uterine cancer despite having their ovaries and fallopian tubes removed, suggest preliminary findings being presented at the Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer in Tampa, Fla., March 22-25.
Scientists at Johns Hopkins have surveyed the DNA in four common types of pancreatic cysts, and have determined that each type bears a distinct pattern of gene mutations. Pancreatic cysts are present in about two percent of U.S. adults, and can, in some cases, require surgical removal and microscopic analysis to determine their type and likelihood of turning cancerous.
The Structural Genomics Consortium (SGC), an Anglo-Canadian charitable consortium of public and private agencies including Oxford University, announced recently that it has delivered its first 50 human and malaria protein structures into the public domain on budget and two months ahead of schedule.
The Royal Society today (Monday 26 April 2004) warned the UK Government that continuing to ignore the concerns of the scientific community over the proposed Human Tissue Bill could cut off vital avenues of research into understanding disease.
On May 29, 2011 XTL has announced that its rHuEPO drug which is currently in preparations for phase 2 clinical trial, has been granted an Orphan-drug designation by the US Food and Drug Administration (FDA) for treatment of Multiple Myeloma blood cancer.
› Verified 7 days ago
Mrs. Christina Sue Taylor, MS CCC SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 3500 Maple Ave, Terre Haute, IN 47804 Phone: 812-238-6986 | |
Haylie Dugan, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1850 E Howard Wayne Blvd, Terre Haute, IN 47802 Phone: 812-232-0406 | |
Kathleen Jeanette Ebert, MS-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2222 Margaret Ave, Terre Haute, IN 47802 Phone: 812-232-2223 | |
Megan Rose Megali, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2901 Ohio Blvd Ste 235, Terre Haute, IN 47803 Phone: 812-328-7300 Fax: 812-328-7400 | |
Alexandra Goff, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1400 Hulman St, Terre Haute, IN 47802 Phone: 812-232-6305 | |
Mrs. Amanda Christine Wolfe, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1450 E Crossing Blvd, Terre Haute, IN 47802 Phone: 812-298-8209 | |
Mrs. Gay L Ruddock, MS LLL-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1606 N 7th St, Terre Haute, IN 47804 Phone: 812-238-7362 |